Obesity Center CGG, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Department of Internal Medicine, Division of Endocrinology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Obes Rev. 2019 Jun;20(6):795-804. doi: 10.1111/obr.12836. Epub 2019 Mar 1.
Obesity is a worldwide growing problem. When confronted with obesity, many health care providers focus on direct treatment of the consequences of adiposity. We plead for adequate diagnostics first, followed by an individualized treatment. We provide experience-based and evidence-based practical recommendations (illustrated by clinical examples), to detect potential underlying diseases and contributing factors. Adult patients consulting a doctor for weight gain or obesity should first be clinically assessed for underlying diseases, such as monogenetic or syndromic obesity, hypothyroidism, (cyclic) Cushing syndrome, polycystic ovarian syndrome (PCOS), hypogonadism, growth hormone deficiency, and hypothalamic obesity. The most important alarm symptoms for genetic obesity are early onset obesity, dysmorphic features/congenital malformations with or without intellectual deficit, behavioral problems, hyperphagia, and/or striking family history. Importantly, also common contributing factors to weight gain should be investigated, including medication (mainly psychiatric drugs, (local) corticosteroids, insulin, and specific β-adrenergic receptor blockers), sleeping habits and quality, crash diets and yoyo-effect, smoking cessation, and alcoholism. Other associated conditions include mental factors such as chronic stress or binge-eating disorder and depression.Identifying and optimizing the underlying diseases, contributing factors, and other associated conditions may not only result in more effective and personalized treatment but could also reduce the social stigma for patients with obesity.
肥胖是一个全球性的问题。当面临肥胖时,许多医疗保健提供者专注于直接治疗肥胖的后果。我们主张首先进行充分的诊断,然后再进行个体化治疗。我们提供基于经验和基于证据的实用建议(通过临床实例说明),以发现潜在的潜在疾病和促成因素。因体重增加或肥胖而咨询医生的成年患者,首先应临床评估潜在疾病,如单基因或综合征性肥胖、甲状腺功能减退症、(周期性)库欣综合征、多囊卵巢综合征 (PCOS)、性腺功能减退症、生长激素缺乏症和下丘脑性肥胖。遗传性肥胖最重要的警报症状是肥胖早发、有或无智力缺陷的畸形特征/先天畸形、行为问题、食欲过盛和/或明显的家族史。重要的是,还应调查体重增加的常见促成因素,包括药物(主要是精神药物、(局部)皮质类固醇、胰岛素和特定的β-肾上腺素能受体阻滞剂)、睡眠习惯和质量、快速节食和溜溜球效应、戒烟和酗酒。其他相关疾病包括慢性压力或暴食障碍和抑郁症等精神因素。识别和优化潜在疾病、促成因素和其他相关疾病不仅可以使治疗更有效和个性化,还可以减少肥胖患者的社会耻辱感。